Precision medicine
Precision medicine is about getting the right treatment to the right patient at the right time. Also know as stratified or personalised medicine, it involves examining the genetic makeup of patients and their differing responses to drugs designed to treat specific diseases. By building up an understanding of the responses and the genetics of the diseases, medical researchers hope to create more personalised and effective forms of treatment for groups of patients most likely to benefit.
Stratified medicine involves examining the genetic makeup of patients and their differing responses to drugs designed to treat specific diseases.
By building up an understanding of the ‘strata’ of responses and the genetics of the diseases, medical researchers hope to create more personalised and effective forms of treatment for groups of patients most likely to benefit.
Industry NHS Academia collaboration
SMS-IC is a unique collaboration comprising the Universities of Glasgow, Edinburgh, Dundee and Aberdeen; NHS Greater Glasgow and Clyde, NHS Grampian, NHS Lothian and NHS Tayside; and the key business partners, global biotechnology company, Thermo Fisher Scientific, and biomedical informatics company, Aridhia Informatics.
Based at the biggest hospital in Europe
Stratified Medicine Scotland is based at the newly opened Queen Elizabeth University Hospital (QEUH) in Glasgow.
The new hospital represents a £1Bn investment into Glasgow and Scotland. The 1,100 bed hospital is one of the largest in Europe and includes maternity, paediatric, adolescent and adult services on a single site. The QEUH serves 41% (2.3 million) of Scotland’s 5.3 million population. Glasgow University, Glasgow City Council and the NHS are investing heavily in additional infrastructure to ensure that there is strong industrial and academic presence embedded at the core of this exciting new hospital.
To find out more about precision medicine you may want to look at the following:
